Physician profile

John L Frattarelli

Reproductive Endocrinology · Kailua, HI

NPI 1356323091

$15,912.81

in general payments reported to CMS, 2019-2025

16 companies · $1,657 in 2025

The $1,657 reported for 2025 was more than what 93% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).

See the full distribution for Reproductive Endocrinology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,171.43
Travel and Lodging$1,053.19

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ferring Pharmaceuticals INC. $12,666.05 2019-2025 Menopur
Granata Bio Corporation $1,413.39 2025
Emd Serono, INC. $572.32 2019-2025
Vitrolife INC. $263.71 2022
Coopersurgical, INC. $257.59 2021-2024 Stripper
Organon LLC $139.44 2021-2025 Nexplanon, Follistim Aq, Ganirelix Acetate
Ferring Pharmaceuticals As $126.88 2022
Covidien LP $120.48 2019
Hologic Sales and Service, LLC $117.61 2021
Merck Sharp & Dohme LLC $106.44 2019-2020
Amgen INC. $42.37 2019
Myriad Genetic Laboratories, INC. $36.36 2021
Astrazeneca Pharmaceuticals LP $22.16 2024 Imfinzi
Sumitomo Pharma America, INC. $15.34 2023 Myfembree
Abbvie INC. $12.67 2019

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John L Frattarelli

$15,912.81

in general payments reported 2019-2025

Years
2019-2025
Top company
Ferring Pharmaceuticals INC.
Context
The $1,657 reported for 2025 was more than what 93% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).

https://glasscript.com/doctor/333320/john-l-frattarelli

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.